publication date: Dec. 23, 2010

In this issue: 

Pryce Introduces Bill To Reimbuse For Orally Administered Cancer Drugs.

H. Lee Moffitt Cancer Designated A Comprehensive Cancer Center By NCI.

DeMets Receives Lectureship On Epidemiology From NIH.

Generic Paclitaxel Approval Withstands Court Challenge.

Obit: J. Gale Katterhagen, NCAB’s First Community Physician.

NCI Invites “Extraordinary Opportunities” For Research. Groups Planning Promotion Of Cancer Clinical Trials.

FDA Approves Xeloda For Colon Cancer; Phase III Data Not Reviewed By ODAC.

M. D. Anderson Buys Record System For In-Patient Services From Atlanta Firm.

Genetronics Phase II Trials For Head & Neck Completed.

Biomira Ends Agreement On Lymphoma Vaccine.

Download (PDF 733KB)

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.